CD40 activation‐induced, Fas‐dependent apoptosis and NF‐κB/AP‐1 signaling in human intrahepatic biliary epithelial cells
暂无分享,去创建一个
D. Adams | S. Afford | L. Young | A. Eliopoulos | J. Ahmed-Choudhury | C. Russell | S. Hubscher | H. Crosby | S. Randhawa | J. Youster
[1] F. Lang,et al. CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa. , 2000, Science.
[2] D. Adams,et al. CD40 Induces Apoptosis in Carcinoma Cells through Activation of Cytotoxic Ligands of the Tumor Necrosis Factor Superfamily , 2000, Molecular and Cellular Biology.
[3] S. Nagata,et al. Fas‐mediated cholangiopathy in the murine model of graft versus host disease , 2000, Hepatology.
[4] J. Stephens,et al. Liver and bile duct pathology following Cryptosporidium parvum infection of immunodeficient mice , 1999, Hepatology.
[5] M. Hecker,et al. Cytokine‐inducible CD40 gene expression in vascular smooth muscle cells is mediated by nuclear factor κB and signal transducer and activato of transcription‐1 , 1999, FEBS letters.
[6] Y. Tao,et al. NF-κB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type , 1999, Cell Death and Differentiation.
[7] Peter Scheurich,et al. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF‐R1 activation by endogenous membrane‐anchored TNF , 1999, The EMBO journal.
[8] J. Simon,et al. Stimulation of CD40 on immunogenic human malignant melanomas augments their cytotoxic T lymphocyte-mediated lysis and induces apoptosis. , 1999, Cancer research.
[9] D. Adams,et al. CD40 Activation Induces Apoptosis in Cultured Human Hepatocytes via Induction of Cell Surface Fas Ligand Expression and Amplifies Fas-mediated Hepatocyte Death during Allograft Rejection , 1999, The Journal of experimental medicine.
[10] P. Galle,et al. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1 /Fas) Mediated apoptosis , 1998, Nature Medicine.
[11] Andrew D. Badley,et al. Transcriptional Regulation of the Human FasL Promoter-Enhancer Region* , 1998, The Journal of Biological Chemistry.
[12] Reinhold Förster,et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells , 1998, Nature.
[13] Y. Nakanuma,et al. Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis , 1997, Hepatology.
[14] D. Adams,et al. Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro. , 1997, Proceedings of the Association of American Physicians.
[15] J. Banchereau,et al. Functions of CD40 on B cells, dendritic cells and other cells. , 1997, Current opinion in immunology.
[16] S. Nagata,et al. Essential roles of the Fas ligand in the development of hepatitis , 1997, Nature Medicine.
[17] J. Banchereau,et al. Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney. , 1997, Kidney international.
[18] L. Notarangelo,et al. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. , 1997, Journal of immunology.
[19] E. Kieff,et al. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator. , 1996, Oncogene.
[20] B. Viollet,et al. Bcl–2 protects from lethal hepatic apoptosis induced by an ant–Fas antibody in mice , 1996, Nature Medicine.
[21] P. Galle,et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage , 1995, The Journal of experimental medicine.
[22] J. Neuberger,et al. Apoptosis in the human liver during allograft rejection and end‐stage liver disease , 1995, The Journal of pathology.
[23] P. Kiener,et al. Expression of functional CD40 by vascular endothelial cells , 1995, The Journal of experimental medicine.
[24] J. Pober,et al. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[25] G Berke,et al. The CTL's kiss of death , 1995, Cell.
[26] D. Harrison,et al. Cell death in health and disease: the biology and regulation of apoptosis. , 1995, Seminars in cancer biology.
[27] R. Joplin. Isolation and culture of biliary epithelial cells. , 1994, Gut.
[28] S. Nagata,et al. Lethal effect of the anti-Fas antibody in mice , 1993, Nature.
[29] J. Neuberger,et al. VANISHING BILE‐DUCT SYNDROME FOLLOWING LIVER TRANSPLANTATION—IS IT REVERSIBLE? , 1991, Transplantation.
[30] L. Young,et al. Identification of a human epithelial cell surface protein sharing an epitope with the C3d/epstein‐barr virus receptor molecule of B lymphocytes , 1989, International journal of cancer.
[31] A. Floreani,et al. Progression of autoimmune damage in primary biliary cirrhosis: an immunohistochemical study. , 1989, Autoimmunity.
[32] S. Sherlock. THE SYNDROME OF DISAPPEARING INTRAHEPATIC BILE DUCTS , 1987, The Lancet.